POTENTIAL THERAPIES FOR TREATMENT OF COVID-19

• Autor(a) principal: Gasser, Beatriz
• Data de Publicação: 2020
• Outros Autores: Andres Ramirez Uscategui, Ricardo
• Tipo de documento: Artigo
• Idioma: eng; spa; por
• Título da fonte: Revista de Ciência Veterinária e Saúde Pública
• Texto Completo: https://periodicos.uem.br/ojs/index.php/RevCiVet/article/view/55502
• topic: antiviral; coronavirus; convalescent plasma; drugs; SARS-CoV-2

Since discovery of the novel coronavirus (SARS-CoV-2) in December of 2019, this viral pneumonia originated in Wuhan, China quickly spread around the world. This new disease, called COVID-19 can cause Acute Respiratory Distress Syndrome (ARDS) due to an uncontrolled inflammatory response like sepsis, that leads to multiple organ failure and even death. Several pharmacotherapeutics alternatives are being tested over the world, looking for most diverse drugs that might be able to fight the infection. The objective of this paper is to review the main pharmacotherapeutics techniques development, as remdesivir, chloroquine/hydroxychloroquine, lopinavir plus ritonavir, interferon-β, ivermectin, anticoagulants, convalescent plasma and vaccine, currently undergoing clinical trials in order to evaluate its effectiveness and safety to combat the COVID-19, presenting their characteristics, possible adverse effects and main scientific findings of its potential action. In conclusion, some therapies presented promising in-vitro results or in the treatment of some patients, nonetheless, multicentric blinded placebo controlled clinical trials are necessary to determine their effectiveness, safety, dosage, and best time point of treatment.